Baclofen News and Research

RSS
Baclofen is a synthetic chlorophenyl-butanoic acid derivative used to treat spasms due to spinal cord damage and multiple sclerosis, muscle-relaxing Baclofen acts as a gamma-aminobutyric acid (GABA) agonist specific for GABA-B receptors. It acts at spinal and supraspinal sites, reducing excitatory transmission.
Baclofen has positive impact on alcohol consumption in patients with ALD

Baclofen has positive impact on alcohol consumption in patients with ALD

Research to help patients suffering from severe spinal cord injuries

Research to help patients suffering from severe spinal cord injuries

Alcoholic liver disease: an interview with Dr Vinood Patel, University of Westminster

Alcoholic liver disease: an interview with Dr Vinood Patel, University of Westminster

Form of baclofen works better at treating narcolepsy

Form of baclofen works better at treating narcolepsy

Study finds that baclofen drug has potential to prevent cocaine relapse

Study finds that baclofen drug has potential to prevent cocaine relapse

Erosive GERD treatments: an interview with Professor Joaquim Moraes-Filho, University of São Paulo Medical School

Erosive GERD treatments: an interview with Professor Joaquim Moraes-Filho, University of São Paulo Medical School

JACS reports study on LINX Reflux Management System for GERD treatment

JACS reports study on LINX Reflux Management System for GERD treatment

Child Neurology Society honors LSUHSC professor with 2012 Hower Award

Child Neurology Society honors LSUHSC professor with 2012 Hower Award

FDA approves Codman’s MEDSTREAM Programmable Infusion System

FDA approves Codman’s MEDSTREAM Programmable Infusion System

Lesogaberan development halts following disappointing results

Lesogaberan development halts following disappointing results

Powerful new technique can manipulate the building-block molecules of organic chemistry

Powerful new technique can manipulate the building-block molecules of organic chemistry

14-3-3 zeta protein involved in generating chronic pain

14-3-3 zeta protein involved in generating chronic pain

XenoPort first quarter revenues increase to $10.4 million

XenoPort first quarter revenues increase to $10.4 million

New editorial offers clarity on confusing drug and alcohol addiction terminology

New editorial offers clarity on confusing drug and alcohol addiction terminology

UofL, Frazier Rehab to establish Spinal Cord Injury Model System

UofL, Frazier Rehab to establish Spinal Cord Injury Model System

Children and adults with social withdrawal due to Fragile X may benefit from STX209

Children and adults with social withdrawal due to Fragile X may benefit from STX209

XenoPort files SPA with FDA for arbaclofen placarbil Phase 3 trial in multiple sclerosis

XenoPort files SPA with FDA for arbaclofen placarbil Phase 3 trial in multiple sclerosis

New Pediatric Physical Medicine and Rehabilitation Service at NewYork-Presbyterian Hospital

New Pediatric Physical Medicine and Rehabilitation Service at NewYork-Presbyterian Hospital

XenoPort reports preliminary top-line results from arbaclofen placarbil Phase 2b clinical trial in GERD

XenoPort reports preliminary top-line results from arbaclofen placarbil Phase 2b clinical trial in GERD

Benefits and underutilization of ITB therapy for multiple sclerosis

Benefits and underutilization of ITB therapy for multiple sclerosis